Integrilin and Stroke - a phase IV clinical study of FDA data
Summary:
Stroke is reported as a side effect among people who take Integrilin (eptifibatide), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Plavix, and have Percutaneous coronary intervention.
The phase IV clinical study analyzes which people have Stroke when taking Integrilin. It is created by eHealthMe based on reports of 3,029 people who have side effects when taking Integrilin from the FDA, and is updated regularly.
What is Integrilin?
Integrilin has active ingredients of eptifibatide. eHealthMe is studying from 3,037 Integrilin users. Check the latest studies of Integrilin.
What is Stroke?
Stroke (sudden death of a portion of the brain cells due to a lack of oxygen) is found to be associated with 2,370 drugs and 3,012 conditions by eHealthMe. Check the latest studies of Stroke.
3,029 people reported to have side effects when taking Integrilin.
Among them, 55 people (1.82%) have Stroke.
Among these 55 people:
How long have people been on Integrilin when they have Stroke? *
What is the gender of people who have Stroke when taking Integrilin? *
What is the age of people who have Stroke when taking Integrilin? *
What are other drugs people take besides Integrilin? *
What are other side effects people have besides Stroke? *
What are the existing conditions these people have? *
* Approximation only. Some reports may have incomplete information.
Do you take Integrilin and have Stroke?
- Check whether Stroke is associated with a drug or a condition (FREE)
- Predict drug outcomes for up to one year with AI (FREE)
- Get an AI agent to monitor your drugs continuously (FREE)
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Integrilin:
- Integrilin (3,037 reports)
Stroke treatments and more:
- Stroke (334,632 reports)
How severe was Stroke and when was it recovered:
Expand to all the drugs that have ingredients of eptifibatide:
- Stroke and drugs with ingredients of eptifibatide (74 reports)
Sub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Common Integrilin side effects:
- Integrilin side effect: Thrombocytopenia (decrease of platelets in blood) (575 reports)
- Integrilin side effect: Haemorrhage (bleeding) (229 reports)
- Integrilin side effect: Gastrointestinal haemorrhage (bleeding gastrointestinal tract) (160 reports)
Browse all side effects of Integrilin:
a b c d e f g h i j k l m n o p q r s t u v w x y zCommon drugs associated with Stroke:
- Vioxx side effect: Stroke (24,895 reports)
- Avandia side effect: Stroke (22,492 reports)
- Aspirin side effect: Stroke (12,887 reports)
- Lipitor side effect: Stroke (6,554 reports)
- Plavix side effect: Stroke (6,381 reports)
- Celebrex side effect: Stroke (5,812 reports)
- Metformin side effect: Stroke (5,698 reports)
- Lisinopril side effect: Stroke (5,666 reports)
- Xarelto side effect: Stroke (5,623 reports)
- Eliquis side effect: Stroke (5,156 reports)
Browse all the drugs that are associated with Stroke:
- Stroke (2,370 drugs)
Common conditions associated with Stroke:
- Diabetes mellitus: 23,761 reports
- Diabetes: 23,701 reports
- Dm: 23,693 reports
- Glucose test: 22,610 reports
- Hypertension: 9,196 reports
- High blood pressure: 9,160 reports
- Hbp: 9,158 reports
- Ra: 8,097 reports
- Multiple sclerosis: 6,970 reports
- Ms hug: 6,943 reports
Browse all the conditions that are associated with Stroke:
- Stroke (3,012 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on eptifibatide (the active ingredients of Integrilin) and Integrilin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Provera and Idiopathic Pulmonary Fibrosis for Women aged 60+ - 3 seconds ago
- Provera and Usual Interstitial Pneumonitis for Women aged 60+ - 3 seconds ago
- Provera and Uip for Women aged 60+ - 3 seconds ago
- Provera and Pulmonary Fibrosis for Women aged 60+ - 3 seconds ago
- Provera and Ipf for Women aged 60+ - 4 seconds ago
- Drug interactions of Detrol La and Terconazole - 4 seconds ago
- Provera and Idiopathic Diffuse Interstitial Pulmonary Fibrosis for Women aged 60+ - 4 seconds ago
- Provera and Cryptogenic Fibrosing Alveolitis for Women aged 60+ - 4 seconds ago
- Provera and Cfa for Women aged 60+ - 5 seconds ago
- Provera and Fibrosing Alveolitis for Women aged 60+ - 5 seconds ago